Atea Pharmaceuticals, Inc.
AVIR
$4.49
$0.143.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.59% | -33.76% | -34.98% | 8.29% | 45.75% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.59% | -122.26% | -64.03% | -65.49% | -42.72% |
| Change in Net Operating Assets | -161.71% | 323.82% | -20.31% | 107.33% | -111.39% |
| Cash from Operations | -51.79% | 7.15% | -75.28% | 22.11% | 23.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.26% | 1,482.55% | 133.85% | -87.74% | 50.71% |
| Cash from Investing | -65.26% | 1,482.55% | 133.85% | -87.74% | 50.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 626.81% | -- | 3.42% | -- | -8.00% |
| Repurchase of Common Stock | -53.81% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 174.06% | -- | -9,762.39% | -- | -331.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.98% | 154.40% | 92.84% | -138.40% | 220.11% |